Exosome therapy pricing confuses almost everyone who researches it: quotes can range from a few hundred dollars to five figures. Understanding what drives the cost is the best defense against both overpaying and dangerously cheap corner-cutting.
The Four Real Cost Drivers
**1. Laboratory production.** Legitimate exosome preparations come from controlled cell-culture processes in professional laboratories, with purification and quality-control steps. This is the largest cost component. Springs Rejuvenation's exosome protocol, for example, is produced in an FDA-approved laboratory — a sourcing standard that costs more than the gray-market alternatives circulating in the industry.
**2. Physician involvement.** A practice where a licensed physician reviews your records, performs your evaluation, and oversees your protocol costs more to operate than one where you only meet a technician.
**3. Protocol scope.** A single localized application differs enormously from a multi-visit protocol. Compare quotes on scope, not just the headline number.
**4. Follow-up structure.** Structured check-ins over 60-90 days are part of responsible care, and they are built into honest pricing.
Why Suspiciously Cheap Is a Red Flag
When a quote is dramatically below market, one of the four drivers above has been cut. In this field, the cut is usually sourcing — and product quality is the one thing a patient cannot verify by looking. Industry analyses have repeatedly found wide variability in the actual vesicle content of commercial "exosome" products, which is why sourcing transparency matters more than price.
Questions That Protect Your Wallet
- Where exactly is the product produced, and can you tell me about the lab?
- What is included: evaluation, procedure, follow-up?
- Who performs the procedure?
- What happens if I'm not a candidate — is the evaluation fee separate?
Keep the Status in Mind
Exosome preparations remain experimental — not an FDA-approved therapy — and Dr. Charles Pereyra's team is explicit about this during Springs Rejuvenation consultations. Paying more does not change the evidence stage; it should buy you better sourcing, real physician oversight, and structured aftercare. That is what the money is actually for.
Our Stem Cell exosome formula is produced in an FDA approved lab, but is not an FDA approved therapy. It is currently in the experimental stages — all information provided is based on our experience with patients. Results may vary.